Commitments and Contingencies (Details Narrative)	1 Months Ended	12 Months Ended
	Oct. 25, 2019	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 EUR (€)
Grant Repyable		$ 422,221
future research and collaboration commitments		1,120,518
Long-term debt payable		4,813,069
Accrued compensation expense		536,535
Royalty Payment		0		$ 1,369
Operating Lease Right of Use Obligations [Member]
Operating Lease Right-of-use liabilities		632,441
Operating Lease Right-of-use Assets		599,816
Operating Lease Liabilities		250,048
Operating Lease Expense		247,390
Short Term Lease Costs		$ 49,988
Tamu [Member]
Debt conversion, Converted instrument, Rate	7.50%
Equity interest in Volition Vet		12.50%	12.50%
Equity Interest	12.50%
Additional interest	5.00%
Two Thousand Twenty Two [Member] | Univercity Of Texas MD [Member]
Collaborative Obligations Amount Due		$ 277,092
Additional Cost Of Company		449,406
August Two Thousand Twenty Three [Member] | Guy's and St Thomas' NHS Foundation Trust [Member]
Collaborative Obligations Amount Due		162,609
Additional Cost Of Company		162,609
Cost		162,338
July Thirty One Thousand Twenty Three [Member] | Xenetic Biosciences Inc and CLS Therapeutics [Member]
Collaborative Obligations Amount Due		26,142
Additional Cost Of Company		107,589
Cost		81,447
January 2024 [Member] | Xenetic Biosciences Inc and CLS Therapeutics [Member]
Collaborative Obligations Amount Due		89,370
Cost		134,055
Managing Director's Agreement [Member]
Royalty Payment		$ 113,856
Royality		6.00%	6.00%
Namur Invest [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2020 [Member]
Loan Agreement Term		10 years	10 years
Repayment Of Long-term Loan Amount | €			€ 830,000
Fixed Interest Rate		4.00%			4.00%
Maturity Date		March 2031	March 2031
Debt Agreement amount | €					€ 556,828
Total Long-term Debt		$ 576,345
Namur Invest One [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2022 [Member]
Loan Agreement Term		4 years	4 years
Repayment Of Long-term Loan Amount | €			€ 500,000
Fixed Interest Rate		5.45%			5.45%
Maturity Date		December 2027	December 2027
Principal Balance Payable		$ 398,497
Agreement Under Amount | €			€ 500,000
Namur Invest Two [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2022 [Member]
Loan Agreement Term		4 years	4 years
Repayment Of Long-term Loan Amount | €			€ 1,000,000
Fixed Interest Rate		6.00%			6.00%
Maturity Date		July 2026	July 2026
Principal Balance Payable		$ 495,160
Agreement Under Amount | €			€ 1,000,000
ING [Member] | Long-term Debt [Member] | In 2016 [Member]
Maturity Date		May 2031	May 2031
Fixed Interest Rate On Lease		2.62%			2.62%
Lease Payable		$ 375,075
ING [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2016 [Member]
Loan Agreement Term		15 years	15 years
Repayment Of Long-term Loan Amount | €			€ 270,000
Fixed Interest Rate		2.62%			2.62%
Maturity Date		December 2031	December 2031
Principal Balance Payable		$ 145,654
Walloon Region Government [Member] | In 2010 [Member]
Repayment Of Grants | €					€ 314,406
Other income | €			€ 733,614
Terms Of Agreement Description		it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is twice the amount of funding received	it is due to pay a 6% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is twice the amount of funding received
Amount Repayable		$ 25,876
Grant Receivable | €					1,048,020
Walloon Region Government [Member] | In 2018 [Member] | Colorectal Cancer Research Agreement [Member]
Repayment Of Grants | €					181,500
Terms Of Agreement Description		it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received	it is due to pay a 3.53% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received
Amount Repayable		$ 84,114
Grant Receivable | €					605,000
Grant Repaid By Installments		over 12 years	over 12 years
Walloon Region Government [Member] | In 2020 [Member]
Repayment Of Grants | €					148,500
Terms Of Agreement Description		it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received	it is due to pay a 2.89% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received
Amount Repayable		$ 82,363
Grant Receivable | €					495,000
Grant Repaid By Installments		over 10 years	over 10 years
Walloon Region Government [Member] | In 2020 [Member] | Colorectal Cancer Research Agreement [Member]
Repayment Of Grants | €					278,830
Terms Of Agreement Description		it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received	it is due to pay a 4.34% royalty on such revenue to the Walloon Region. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
Amount Repayable		$ 229,868
Grant Receivable | €					€ 929,433
Grant Repaid By Installments		over 15 years	over 15 years
SOFINEX [Member] | Long-term Debt [Member] | Loan Agreement [Member] | November 23, 2021 [Member]
Loan Agreement Term		3 years 5 months 30 days	3 years 5 months 30 days
Repayment Of Long-term Loan Amount | €			€ 450,000
Fixed Interest Rate		5.00%			5.00%
Maturity Date		June 2025	June 2025
Principal Balance Payable		$ 116,443
Agreement Under Amount | €			€ 450,000
SOFINEX [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2017 [Member]
Loan Agreement Term		7 years	7 years
Repayment Of Long-term Loan Amount | €			€ 1,000,000
Fixed Interest Rate		4.50%			4.50%
Maturity Date		September 2024	September 2024
Total Long-term Debt		$ 51,753
University of Taiwan [Member] | Clinical Study Research Agreement [Member] | In 2018 [Member]
Collaborative Obligations Amount Due		510,000
Collaborative Obligations Amount		$ 2,550,000
Lease Agreement Expire Period		3 years	3 years
Namur Invest Three [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2023 [Member]
Loan Agreement Term		4 years	4 years
Repayment Of Long-term Loan Amount | €			€ 400,000
Fixed Interest Rate		7.00%			7.00%
Maturity Date		June 2027	June 2027
Principal Balance Payable		$ 360,883
Agreement Under Amount | €			€ 400,000
Wallonie Enterprendre [Member] | Long-term Debt [Member] | Loan Agreement [Member] | In 2023 [Member]
Loan Agreement Term		5 years	5 years
Repayment Of Long-term Loan Amount | €			€ 2,500,000
Fixed Interest Rate		7.68%			7.68%
Maturity Date		December 2028	December 2028
Principal Balance Payable		$ 2,070,100
Agreement Under Amount | €			€ 1,500,000
Namur Invest Four [Member] | Long-term Debt [Member] | Loan Agreement [Member]
Loan Agreement Term		4 years	4 years
Repayment Of Long-term Loan Amount | €			€ 577,975
Fixed Interest Rate		7.00%			7.00%
Maturity Date		September 2028	September 2028
Principal Balance Payable		$ 598,234
Agreement Under Amount | €			€ 577,975
Restricted Stock Units [Member]
Recognized total compensation expense		1,439,767		$ 527,940
RSU Vested in 2023		516,039
RSU Vested in 2024		395,788
Unrecognized compensation expense		115,142
Restricted Stock Units [Member] | One
Recognized total compensation expense		494,812
RSU Vested in 2023		0
RSU Vested in 2024		80,175
Unrecognized compensation expense		$ 205,730